Multifaceted role of lipids in Mycobacterium leprae

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Pieters J, Gatfield J. Hijacking the host: survival of pathogenic mycobacteria inside macrophages. Trends Microbiol. 10(3), 142–146 (2002).
  Medline CASGoogle Scholar
• 2 Jarlier V, Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123(1–2), 11–18 (1994).
  Medline CASGoogle Scholar
• 3 Zu Bentrup KH, Russell DG. Mycobacterial persistence: adaptation to a changing environment. Trends Microbiol. 9(12), 597–605 (2001).
  MedlineGoogle Scholar
• 4 Neyrolles O, Hernández-Pando R, Pietri-Rouxel F et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE 1(1), e43 (2006).
  MedlineGoogle Scholar
• 5 Ehrt S, Schnappinger D. Mycobacterium tuberculosis virulence: lipids inside and out. Nat. Med. 13(3), 284–285 (2007).
  Medline CASGoogle Scholar
• 6 Mendum TA, Wu H, Kierzek AM, Stewart GR. Lipid metabolism and Type VII secretion systems dominate the genome scale virulence profile of Mycobacterium tuberculosis in human dendritic cells. BMC Genomics 16(1), 1 (2015).
  Medline CASGoogle Scholar
• 7 Bacon J, Dover LG, Hatch KA et al. Lipid composition and transcriptional response of Mycobacterium tuberculosis grown under iron-limitation in continuous culture: identification of a novel wax ester. Microbiology 153(5), 1435–1444 (2007).
  Medline CASGoogle Scholar
• 8 Gengenbacher M, Kaufmann SH. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol. Rev. 36(3), 514–532 (2012).
  Medline CASGoogle Scholar
• 9 Minnikin DE, Lee OY-C, Wu HH et al. Ancient mycobacterial lipids: key reference biomarkers in charting the evolution of tuberculosis. Tuberculosis 95, S133–S139 (2015).
  Medline CASGoogle Scholar
• 10 Wang H, Maeda Y, Fukutomi Y, Makino M. An in vitro model of Mycobacterium leprae induced granuloma formation. BMC Infect. Dis. 13(1), 1 (2013).
  MedlineGoogle Scholar
• 11 Levy L, Ji B. The mouse foot-pad technique for cultivation of Mycobacterium leprae. Lepr. Rev. 77(1), 5 (2006).
  MedlineGoogle Scholar
• 12 Yuan Y, Zhu Y, Crane DD, Barry CE III. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol. Microbiol. 29(6), 1449–1458 (1998).
  Medline CASGoogle Scholar
• 13 Rajni, Rao N, Meena LS. Biosynthesis and virulent behavior of lipids produced by Mycobacterium tuberculosis: LAM and cord factor: an overview. Biotechnol. Res. Int. 2011, 274693 (2011).
  Medline CASGoogle Scholar
• 14 Lee OY, Wu HH, Besra GS et al. Lipid biomarkers provide evolutionary signposts for the oldest known cases of tuberculosis. Tuberculosis 95, S127–S132 (2015).
  Medline CASGoogle Scholar
• 15 De Libero G, Mori L. The T-cell response to lipid antigens of Mycobacterium tuberculosis. Front. Immunol. 5, 219 (2014).
  MedlineGoogle Scholar
• 16 Moura A, Mariano M. Lipids from Mycobacterium leprae cell wall are endowed with an anti-inflammatory property and inhibit macrophage function in vivo. Immunology 89(4), 613–618 (1996).
  Medline CASGoogle Scholar
• 17 Moura A, Mariano M. Lipids from Mycobacterium leprae cell wall suppress T-cell activation in vivo and in vitro. Immunology 92(4), 429–436 (1997).
  Medline CASGoogle Scholar
• 18 Baeza I, Wong-Baeza C, Valerdi E et al. Lepromatous leprosy patients produce antibodies that recognise non-bilayer lipid arrangements containing mycolic acids. Mem. Inst. Oswaldo Cruz 107, 95–103 (2012).
  Medline CASGoogle Scholar
• 19 Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 83(1), 91–97 (2003).
  Medline CASGoogle Scholar
• 20 Bhamidi S, Scherman MS, Jones V et al. Detailed structural and quantitative analysis reveals the spatial organization of the cell walls of in vivo grown Mycobacterium leprae and in vitro grown Mycobacterium tuberculosis. J. Biol. Chem. 286(26), 23168–23177 (2011).
  Medline CASGoogle Scholar
• 21 Cole S, Eiglmeier K, Parkhill J et al. Massive gene decay in the leprosy bacillus. Nature 409(6823), 1007–1011 (2001). •• Gives excellent knowledge about reductive evolution in Mycobacterium leprae. A good account of the number of genes in various categories is given in comparison to M. tuberculosis.
  Medline CASGoogle Scholar
• 22 Kai M, Fujita Y, Maeda Y et al. Identification of trehalose dimycolate (cord factor) in Mycobacterium leprae. FEBS Lett. 581(18), 3345–3350 (2007).
  Medline CASGoogle Scholar
• 23 Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol. Rev. 35(6), 1126–1157 (2011).
  Medline CASGoogle Scholar
• 24 Scollard D, Adams L, Gillis T, Krahenbuhl J, Truman R, Williams D. The continuing challenges of leprosy. Clin. Microbiol. Rev. 19(2), 338–381 (2006).
  Medline CASGoogle Scholar
• 25 Brennan PJ, Barrow WW. Evidence for species-specific lipid antigens in Mycobacterium leprae. Int. J. Lepr. Other Mycobact. Dis. 48(4), 382–387 (1980).
  Medline CASGoogle Scholar
• 26 Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53(2), 391–403 (2004).
  Medline CASGoogle Scholar
• 27 Minnikin DE, Kremer L, Dover LG, Besra GS. The methyl-branched fortifications of Mycobacterium tuberculosis. Chem. Biol. 9(5), 545–553 (2002).
  Medline CASGoogle Scholar
• 28 Ducati RG, Ruffino-Netto A, Basso LA, Santos DS. The resumption of consumption: a review on tuberculosis. Mem. Inst. Oswaldo Cruz 101(7), 697–714 (2006).
  Medline CASGoogle Scholar
• 29 Bansal-Mutalik R, Nikaido H. Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides. Proc. Natl Acad. Sci. 111(13), 4958–4963 (2014).
  Medline CASGoogle Scholar
• 30 Melancon-Kaplan J, Hunter SW, Mcneil M et al. Immunological significance of Mycobacterium leprae cell walls. Proc. Natl Acad. Sci. 85(6), 1917–1921 (1988).
  Medline CASGoogle Scholar
• 31 Daffe M, Etienne G. The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tuber. Lung. Dis. 79, 153–169 (1999).
  Medline CASGoogle Scholar
• 32 Draper P, Payne SN, Dobson G, Minnikin D. Isolation of a characteristic phthiocerol dimycocerosate from Mycobacterium leprae. Microbiology 129(3), 859–863 (1983).
  CASGoogle Scholar
• 33 Daffe M, Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39, 131–203 (1998).
  Medline CASGoogle Scholar
• 34 Hunter SW, Brennan PJ. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol. 147(3), 728–735 (1981).
  Medline CASGoogle Scholar
• 35 Rastogi N. Recent observations concerning structure and function relationships in themycobacterial cell envelope: elaboration of a model in terms of mycobacterialpathogenicity, virulence and drug-resistance. Res. Microbiol. 142(4), 464–476 (1999).
  Google Scholar
• 36 Julián E, Matas L, Pérez A et al. Serodiagnosis of tuberculosis: comparison of immunoglobulin a (IgA) response to sulfolipid I with IgG and IgM responses to 2,3-diacyltrehalose, 2,3,6-triacyltrehalose, and cord factor antigens. J. Clin. Microbiol. 40(10), 3782–3788 (2002).
  Medline CASGoogle Scholar
• 37 Vissa VD, Brennan PJ. The genome of Mycobacterium leprae: a minimal mycobacterial gene set. Genome Biol. 2(8), 1 (2001).
  Google Scholar
• 38 Rhoades ER, Streeter C, Turk J et al. Characterization of sulfolipids of Mycobacterium tuberculosis H37Rv by multiple-stage linear ion-trap high-resolution mass spectrometry with electrospray ionization reveals that the family of sulfolipid II predominates. Biochemistry 50(42), 9135–9147 (2011).
  Medline CASGoogle Scholar
• 39 Chatterjee D, Khoo KH, McNeil MR, Dell A, Morris HR, Brennan PJ. Structural definition of the non-reducing termini of mannose-capped LAMfrom Mycobacterium tuberculosis through selective enzymatic degradationand fast atom bombardment-mass spectrometry. Glycobiol. 3, 497–506 (1993).
  Medline CASGoogle Scholar
• 40 Chatterjee D, Khoo KH. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan withprofound physiological effects. Glycobiol. 8, 113–120 (1998).
  Medline CASGoogle Scholar
• 41 Kai M, Fujita Y, Maeda Y, Nakata N. Identification of trehalose dimycolate (cord factor) in Mycobacterium leprae. FEBS Lett. 581(18), 3345–3350 (2007).
  Medline CASGoogle Scholar
• 42 Quadri LE. Biosynthesis of mycobacterial lipids by polyketide synthases and beyond. Crit. Rev. Biochem. Mol. Biol. 49(3), 179–211 (2014).
  Medline CASGoogle Scholar
• 43 Spencer JS, Brennan PJ. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Lepr. Rev. 82(4), 344 (2011).
  MedlineGoogle Scholar
• 44 Dagur PK, Sharma B, Upadhyay R et al. Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR- and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases. Lipids Health Dis. 11(1), 1 (2012).
  MedlineGoogle Scholar
• 45 Ng V, Zanazzi G, Timpl R et al. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 103(3), 511–524 (2000). • M. leprae has a unique preference for Schwann cells. This publication explains why and at the same time highlights the importance of phenolic glycolipid-1 in M. leprae.
  Medline CASGoogle Scholar
• 46 Murray RA, Siddiqui MR, Mendillo M, Krahenbuhl J, Kaplan G. Mycobacterium leprae inhibits dendritic cell activation and maturation. J. Immunol. 178(1), 338–344 (2007).
  Medline CASGoogle Scholar
• 47 Tabouret G, Astarie-Dequeker C, Demangel C et al. Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. PLoS Pathog. 6(10), e1001159 (2010).
  MedlineGoogle Scholar
• 48 Schlesinger LS, Horwitz MA. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J. Exp. Med. 174(5), 1031–1038 (1991).
  Medline CASGoogle Scholar
• 49 Ortalo-Magne A, Lemassu A, Laneelle M-A et al. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178(2), 456–461 (1996).
  Medline CASGoogle Scholar
• 50 Lastória JC, Abreu MA. Leprosy: a review of laboratory and therapeutic aspects – part 2. An. Bras. Dermatol. 89(3), 389–401 (2014). •• Gives a good account of various diagnostic candidates of leprosy.
  MedlineGoogle Scholar
• 51 Levy RA, De Meis E, Pierangeli S. An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay. Thromb. Res. 114(5), 573–577 (2004).
  Medline CASGoogle Scholar
• 52 Van Der Meer-Janssen YP, Van Galen J, Batenburg JJ, Helms JB. Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome. Prog. Lipid Res. 49(1), 1–26 (2010).
  Medline CASGoogle Scholar
• 53 Chatterjee K, Gupta ND, De M. Electron microscopic observations on the morphology of Mycobacterium leprae. Exp. Cell Res. 18(3), 521–527 (1959).
  Medline CASGoogle Scholar
• 54 de Mattos KA, Sarno EN, Pessolani MC, Bozza PT. Deciphering the contribution of lipid droplets in leprosy: multifunctional organelles with roles in Mycobacterium leprae pathogenesis. Mem. Inst. Oswaldo Cruz 107, 156–166 (2012). •• First of its kind which gives a very good account of the contribution of lipid droplets (LDs) in the survival and virulence of M. leprae.
  MedlineGoogle Scholar
• 55 Elamin AA, Stehr M, Singh M. Lipid droplets and Mycobacterium leprae infection. J. Pathog. 2012, 361374 (2012).
  MedlineGoogle Scholar
• 56 Mattos KA, D'avila H, Rodrigues LS et al. Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J. Leukoc. Biol. 87(3), 371–384 (2010). • Mechanisms governing the formation of LDs are given in detail as their role as immunomodulatory platforms.
  Medline CASGoogle Scholar
• 57 Bozza PT, Magalhães KG, Weller PF. Leukocyte lipid bodies-biogenesis and functions in inflammation. Biochim. Biophys. Acta 1791(6), 540–551 (2009).
  Medline CASGoogle Scholar
• 58 Deb C, Lee C-M, Dubey VS et al. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS ONE 4(6), e6077 (2009).
  MedlineGoogle Scholar
• 59 Vergne I, Chua J, Singh SB, Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell Dev. Biol. 20, 367–394 (2004).
  Medline CASGoogle Scholar
• 60 Meena LS. Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J. 277(11), 2416–2427 (2010).
  Medline CASGoogle Scholar
• 61 Cole S, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685), 537–544 (1998).
  Medline CASGoogle Scholar
• 62 Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7(6), e1002093 (2011). •• Mechanism of LD formation in M. tuberculosis is explained and origin of lipids which constitute it. Source of nutrition for M. tuberculosis during dormancy is well documented.
  Medline CASGoogle Scholar
• 63 Low KL, Shui G, Natter K et al. Lipid droplet-associated proteins are involved in the biosynthesis and hydrolysis of triacylglycerol in Mycobacterium bovis bacillus Calmette-Guerin. J. Biol. Chem. 285(28), 21662–21670 (2010).
  Medline CASGoogle Scholar
• 64 Gautam US, Sikri K, Vashist A, Singh V, Tyagi JS. Essentiality of DevR/DosR interaction with SigA for the dormancy survival program in Mycobacterium tuberculosis. J. Bacteriol. 196(4), 790–799 (2014).
  MedlineGoogle Scholar
• 65 Gautam US, Mcgillivray A, Mehra S et al. DosS is required for the complete virulence of Mycobacterium tuberculosis in mice with classical granulomatous lesions. Am. J. Respir. Cell Mol. Biol. 52(6), 708–716 (2015).
  Medline CASGoogle Scholar
• 66 Salamon H, Bruiners N, Lakehal K et al. Cutting edge: vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection. J. Immunol. 193(1), 30–34 (2014).
  Medline CASGoogle Scholar
• 67 Robinson N, Kolter T, Wolke M, Rybniker J, Hartmann P, Plum G. Mycobacterial phenolic glycolipid inhibits phagosome maturation and subverts the pro-inflammatory cytokine response. Traffic 9(11), 1936–1947 (2008).
  Medline CASGoogle Scholar
• 68 Mattos KA, Oliveira VC, Berrêdo-Pinho M et al. Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment. Cell. Microbiol. 16(6), 797–815 (2014). •• Establishes cholesterol as one of the most important lipid for M. leprae as well as a future drug candidate.
  Medline CASGoogle Scholar
• 69 Cruz D, Watson AD, Miller CS et al. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J. Clin. Invest. 118(8), 2917–2928 (2008).
  Medline CASGoogle Scholar
• 70 Brennan PJ. Mycobacterium leprae – the outer lipoidal surface. J. Biosci. 6(5), 685–689 (1984).
  CASGoogle Scholar
• 71 Fisher CA, Barksdale L. Cytochemical reactions of human leprosy bacilli and mycobacteria: ultrastructural implications. J. Bacteriol. 113(3), 1389–1399 (1973).
  Medline CASGoogle Scholar
• 72 Kaplan G, Van Voorhis WC, Sarno EN, Nogueira N, Cohn ZA. The cutaneous infiltrates of leprosy. A transmission electron microscopy study. J. Exp. Med. 158(4), 1145–1159 (1983).
  Medline CASGoogle Scholar
• 73 Sakurai I, Skinsnes O. Lipids in leprosy. 1. Histochemistry of lipids in murine leprosy. Int. J. Lepr. 38(4), 379–388 (1970).
  CASGoogle Scholar
• 74 Degang Y, Akama T, Hara T et al. Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages. PLoS Negl. Trop. Dis. 6(12), e1936 (2012).
  Medline CASGoogle Scholar
• 75 Tanigawa K, Degang Y, Kawashima A et al. Essential role of hormone-sensitive lipase (HSL) in the maintenance of lipid storage in Mycobacterium leprae-infected macrophages. Microb. Pathog. 52(5), 285–291 (2012). • Highlights the host dependency of M. leprae for lipolytic enzymes.
  Medline CASGoogle Scholar
• 76 Suzuki K, Takeshita F, Nakata N, Ishii N, Makino M. Localization of CORO1A in the macrophages containing Mycobacterium leprae. Acta Histochem. Cytochem. 39(4), 107–112 (2006).
  Medline CASGoogle Scholar
• 77 Kim MJ, Wainwright HC, Locketz M et al. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2(7), 258–274 (2010).
  Medline CASGoogle Scholar
• 78 Singh V, Jamwal S, Jain R, Verma P, Gokhale R, Rao KV. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe. 12(5), 669–681 (2012).
  Medline CASGoogle Scholar
• 79 Betz M, Fox B. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146(1), 108–113 (1991).
  Medline CASGoogle Scholar
• 80 Kiszewski A, Becerril E, Baquera J, Ruiz-Maldonado R, Hernandez Pando R. Expression of cyclooxygenase type 2 in lepromatous and tuberculoid leprosy lesions. Br. J. Dermatol. 148(4), 795–798 (2003).
  Medline CASGoogle Scholar
• 81 Schmid B, Rippmann JF, Tadayyon M, Hamilton BS. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem. Biophys. Res. Commun. 328(4), 1073–1082 (2005).
  Medline CASGoogle Scholar
• 82 Samsa MM, Mondotte JA, Iglesias NG et al. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5(10), e1000632 (2009).
  MedlineGoogle Scholar
• 83 D'avila H, Roque NR, Cardoso RM, Castro-Faria-Neto HC, Melo RC, Bozza PT. Neutrophils recruited to the site of Mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E2 production by macrophages. Cell. Microbiol. 10(12), 2589–2604 (2008).
  MedlineGoogle Scholar
• 84 Persson J, Nilsson J, Lindholm MW. Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol. 9(1), 1 (2008).
  MedlineGoogle Scholar
• 85 Marques MaM, Berrêdo-Pinho M, Rosa TL et al. The essential role of cholesterol metabolism in the intracellular survival of Mycobacterium leprae is not coupled to central carbon metabolism and energy production. J. Bacteriol. 197(23), 3698–3707 (2015).
  Medline CASGoogle Scholar
• 86 Astarie-Dequeker C, Le Guyader L, Malaga W et al. Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids. PLoS Pathog. 5(2), e1000289 (2009).
  MedlineGoogle Scholar
• 87 Lee W, Vanderven BC, Fahey RJ, Russell DG. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J. Biol. Chem. 288(10), 6788–6800 (2013).
  Medline CASGoogle Scholar
• 88 Luo M, Fadeev EA, Groves JT. Mycobactin-mediated iron acquisition within macrophages. Nat. Chem. Biol. 1(3), 149–153 (2005).
  Medline CASGoogle Scholar
• 89 Singh P, Cole ST. Mycobacterium leprae: genes, pseudogenes and genetic diversity. Future Microbiol. 6(1), 57–71 (2011).
  CASGoogle Scholar
• 90 Wheeler P. Oxidation of carbon sources through the tricarboxylic acid cycle in Mycobacterium leprae grown in armadillo liver. Microbiology 130(2), 381–389 (1984).
  CASGoogle Scholar
• 91 Singh VK, Srivastava V, Singh V et al. Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice. Vaccine 29(29), 4754–4760 (2011).
  Medline CASGoogle Scholar
• 92 Saxena AK, Roy KK, Singh S et al. Identification and characterisation of small-molecule inhibitors of Rv3097c-encoded lipase (LipY) of Mycobacterium tuberculosis that selectively inhibit growth of bacilli in hypoxia. Int. J. Antimicrob. Agents 42(1), 27–35 (2013).
  Medline CASGoogle Scholar
• 93 Singh G, Arya S, Kaur J. Rv2485c, a putative lipase of M. tuberculosis: expression, purification and biochemical characterization. Int. J. Trop. Dis. Health 4(1), 1–17 (2014).
  CASGoogle Scholar
• 94 Singh G, Arya S, Narang D et al. Characterization of an acid inducible lipase Rv3203 from Mycobacterium tuberculosis H37Rv. Mol. Biol. Rep. 41(1), 285–296 (2014).
  Medline CASGoogle Scholar
• 95 Singh G, Arya S, Kumar A, Narang D, Kaur J. Molecular characterization of oxidative stress-inducible LipD of Mycobacterium tuberculosis H37Rv. Curr. Microbiol. 68(3), 387–396 (2014).
  Medline CASGoogle Scholar
• 96 Shen G, Chandra D, Serveau Avesque C, Maurin D, Canaan S, Laal S. LipC(Rv0220) is an immunogenic cell surface esterase of Mycobacterium tuberculosis. Infect. Immun. 80, 243–253 (2012).
  Medline CASGoogle Scholar
• 97 Richter L, Saviola B. The lipF promoter of Mycobacteriumtuberculosis is upregulated specifically by acidic pH but not by otherstress conditions. Microbiol. Res. 164, 228–232 (2009).
  Medline CASGoogle Scholar
• 98 Zhang M, Wang J, Li Z, Xie J, Yang Y, Zhong Y, Wang H. Expression and characterization of the carboxylesterase Rv3487c from Mycobacterium tuberculosis. Prot. Exp. Purific. 42, 59–66 (2005).
  Medline CASGoogle Scholar
• 99 Camacho LR, Ensergueix D, Perez E, Gicquel B. Identification of a virulence genecluster of Mycobacterium tuberculosis bysignature-tagged transposon mutagenesis. Mol. Microbiol. 34(2), 257–267 (1999).
  Medline CASGoogle Scholar
• 100 Canaan S, Maurin D, Chahinian H, Pouilly B, Durousseau C, Frassinetti F, Bourne Y. Expression andcharacterization of the protein Rv1399c from Mycobacterium tuberculosis. Biochem. 271, 3953–3961 (2004).
  CASGoogle Scholar
• 101 Lee JH, Karakousis PC, Bishai WR. Roles of SigB and SigF in the Mycobacterium tuberculosis sigma factornetwork. J. Bacteriol. 190(2), 699–707 (2008).
  Medline CASGoogle Scholar
• 102 Sinha SC, Wetterer M, Sprang SR, Schultz JE, Linder JU. Origin of asymmetryin adenylyl cyclases: structures of Mycobacterium tuberculosis Rv1900c. EMBO J. 24(4), 663–673 (2005).
  Medline CASGoogle Scholar
• 103 Gu S, Chen J, Dobos KM, Bradbury EM, Belisle JT, Chen X. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol. Cell Proteomics 2(12), 1284–1296 (2003).
  Medline CASGoogle Scholar
• 104 Jadeja D, Dogra N, Arya S, Singh G, Singh G, Kaur J. Characterization of LipN (Rv2970c) of Mycobacterium tuberculosis H37Rv and its probable role inxenobiotic degradation. J. Cell Biochem. 117, 390–401 (2016).
  Medline CASGoogle Scholar
• 105 Singh R, Singh A, Tyagi AK. Deciphering the genes involved inpathogenesis of Mycobacterium tuberculosis. Tuberculosis 85(5–6), 325–335 (2005).
  Medline CASGoogle Scholar
• 106 Dahl JL, Kraus CN, Boshoff HIM, Doan B, Foley K, Avarbock D, Kaplan G, Mizraji V, Barry CE. The role of Rel(Mtb)-mediated adaptation to stationaryphase in long-term persistence of Mycobacterium tuberculosis inmice. Proc. Natl Acad. Sci. 100, 10026–10031 (2003).
  Medline CASGoogle Scholar
• 107 Sheline KD, France AM, Talarico S, Foxman B, Zhang L, Marrs CF, Yang Z. Does the lipR gene of tuberclebacilli have a role in tuberculosis transmission and pathogenesis?. Tuberculosis 89, 114–119 (2009).
  Medline CASGoogle Scholar
• 108 Galagan JE, Minch K, Peterson M, Lyubetskaya A. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499, 178–183 (2013).
  Medline CASGoogle Scholar
• 109 Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvationmodel of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43, 717–731 (2002).
  Medline CASGoogle Scholar
• 110 Rindi L, Fattorini L, Bonanni D et al. Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice. Microbiology 148(12), 3873–3880 (2002).
  Medline CASGoogle Scholar
• 111 Daniel J, Sirakova T, Kolattukudy P. An acyl-CoA synthetase in Mycobacterium tuberculosis involved in triacylglycerol accumulation during dormancy. PLoS ONE 9(12), e114877 (2014).
  MedlineGoogle Scholar
• 112 Akama T, Tanigawa K, Kawashima A, Wu H, Ishii N, Suzuki K. Analysis of Mycobacterium leprae gene expression using DNA microarray. Microb. Pathog. 49(4), 181–185 (2010).
  Medline CASGoogle Scholar
• 113 Sirakova TD, Dubey VS, Deb C et al. Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. Microbiology 152(9), 2717–2725 (2006).
  Medline CASGoogle Scholar
• 114 Boritsch EC, Frigui W, Cascioferro A et al. pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence. Nat. Microbiol. 1, 15019 (2016). • Establishes pks as a marker of virulence for M. tuberculosis and marks the evolution of M. tuberculosis from less virulent mycobacteria like M. canetti.
  Medline CASGoogle Scholar
• 115 Onwueme KC, Ferreras JA, Buglino J, Lima CD, Quadri LE. Mycobacterial polyketide-associated proteins are acyltransferases: proof of principle with Mycobacterium tuberculosis PapA5. Proc. Natl Acad. Sci. USA 101(13), 4608–4613 (2004).
  Medline CASGoogle Scholar
• 116 Fujiwara T, Hunter S, Cho S, Aspinall G, Brennan P. Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect. Immun. 43(1), 245–252 (1984).
  Medline CASGoogle Scholar
• 117 Al-Mubarak R, Vander Heiden J, Broeckling CD, Balagon M, Brennan PJ, Vissa VD. Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. PLoS Negl. Trop. Dis. 5(9), e1303 (2011).
  Medline CASGoogle Scholar
• 118 Yang L, Ding Y, Chen Y, Zhang S, Huo C, Wang Y, Yu J. The proteomics of lipid droplets: structure, dynamics, and functions of the organelle conserved from bacteria to humans. J. Lipid Res. 53, 1245–1253 (2012).
  Medline CASGoogle Scholar
• 119 Camacho LR, Constant P, Raynaud C et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276(23), 19845–19854 (2001).
  Medline CASGoogle Scholar